METTL14 and diabetic cardiomyopathy: LncRNA Airn alleviates cardiac fibrosis in diabetic cardiomyopathy by inhibiting ubiquitination degradation of IMP2 (encoded by IGF2BP2) and stabilizing p53 mRNA in an m6A-dependent manner.325 METTL14 seems to be a risk factor in doxorubicin (DOX)-induced cardiomyopathy by promoting ferroptosis.326